All In MedTech

Device Trial Radar · NCT07027267

Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery

A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of TurbAlign™ to Achieve Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery (FESS) (GAIA)

Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

50

Actual

Start

Aug 4, 2025

Primary completion

May 5, 2026

Study completion Jul 31, 2026

Sponsor

Lead sponsor
Spirair, IncNot on our public-company list
Sponsor type
Industry
First posted
Jun 18, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery

Conditions

  • Sinus Endoscopic Surgery
  • Turbinate

Interventions

  • Implantation of Spirair device into the middle turbinatesDevice

    The Spirair implant is designed to separate the middle turbinate from the lateral nasal wall during the healing phase associated with nasal/sinus surgery.

  • TurbAlignDevice

    The Spirair implant is designed to separate the middle turbinate from the lateral nasal wall during the healing phase associated with nasal/sinus surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Miller Synechia ScoreTime frame: 8 Weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Northwest Community Hospital

    Arlington Heights, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • Tandem Clinical Research

    Marrero, Louisiana

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.